These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 16875623

  • 1. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX, Lin JS, Song YH, Li PY, Tao LW.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
    Chen XL, Wang Q, Cao LQ, Huang XH, Fu XH, Tan HX, Zhen MC, Chen JS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2524-8. PubMed ID: 19080641
    [Abstract] [Full Text] [Related]

  • 8. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K, Shiraki K, Fuke H, Inoue T, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Aug 23; 18(2):249-56. PubMed ID: 16820931
    [Abstract] [Full Text] [Related]

  • 9. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity.
    Ohuchida T, Okamoto K, Akahane K, Higure A, Todoroki H, Abe Y, Kikuchi M, Ikematsu S, Muramatsu T, Itoh H.
    Cancer; 2004 Jun 01; 100(11):2430-6. PubMed ID: 15160348
    [Abstract] [Full Text] [Related]

  • 10. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL.
    Ganten TM, Koschny R, Haas TL, Sykora J, Li-Weber M, Herzer K, Walczak H.
    Hepatology; 2005 Sep 01; 42(3):588-97. PubMed ID: 16037944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y, Hu MY, Chen BH, Wang ZJ, Zha XL, Liu KD.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):530-5. PubMed ID: 16681881
    [Abstract] [Full Text] [Related]

  • 13. [Synergistic lethal effect of mDRA-6 and nimesulide on human hepatocellular cancer cell line SMMC-7721].
    Liu YJ, Ma YF, Zhang J, Zhao YP, Bai HL, Li SL.
    Ai Zheng; 2008 Apr 28; 27(4):374-8. PubMed ID: 18423123
    [Abstract] [Full Text] [Related]

  • 14. [Effects of hTERT RNAi on apoptosis of hepatocellular carcinoma cells induced by TRAIL].
    Zhang RG, Fang DC, Luo YH, Guo LP.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun 28; 14(6):435-40. PubMed ID: 16792868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 17. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Ai Zheng; 2006 May 15; 25(5):526-32. PubMed ID: 16687068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line.
    Cao L, Li Y, Cheng F, Li S, Long D.
    Transplant Proc; 2006 Sep 15; 38(7):2207-9. PubMed ID: 16980044
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.